Different mechanisms are involved in intracellular calcium increase by insulin-like growth factors 1 and 2 in articular chondrocytes: Voltage-gated calcium channels, and/or phospholipase C coupled to a pertussis-sensitive G-protein
Abstract:This study describes the mechanisms involved in the IGF-1 and IGF-2-induced increases in intracellular calcium concentration [Ca2+]i in cultured chondrocytes and the involvement of type 1 IGF receptors. It shows that IGF-1, IGF-2, and insulin increased the cytosolic free calcium concentration [Ca2+]i in a dose-dependent manner, with a plateau from 25 to 100 ng/ml for both IGF-1 and IGF-2 and from 1 to 2 micrograms/ml for insulin. The effect of IGF-1 was twice as great as the one of IGF-2, and the effect of ins… Show more
“…Moreover, Rg5 promoted Ca 2ϩ -dependent eNOS dimerization and NO production, which were mediated by the G i -mediated PLC pathway. These data are consistent with previous results in which IGF-1R activated G i -mediated PLC activation and Ca 2ϩ mobilization (27,28). Inhibitors of these signal mediators suppressed Rg5-mediated FAK activation and angiogenesis, suggesting that G i protein-mediated elevation of [Ca 2ϩ ] i is responsible for FAK phosphorylation (35).…”
Section: Discussionsupporting
confidence: 93%
“…5A). Activation of the G i protein complex stimulates PLC activation and Ca 2ϩ mobilization, resulting in promotion of cell growth and migration (27,28). We next examined whether Rg5 regulates the G i protein-mediated PLC/Ca 2ϩ pathway.…”
Section: Rg5-induced Angiogenesis Requires G I Protein Plc and Camentioning
Background:The mechanism by which ginsenoside Rg5 regulates vascular function remains unclear. Results: Rg5 increases angiogenesis and vasorelxation by activating multiple signal transduction pathways downstream of insulin-like growth fastor-1 receptor (IGF-1R). Conclusion: Rg5 promotes endothelial cell function through activation of IGF-1R. Significance: These findings reveal a mechanism for the positive regulation of vascular function by Rg5-mediated IGF-1R activation.
“…Moreover, Rg5 promoted Ca 2ϩ -dependent eNOS dimerization and NO production, which were mediated by the G i -mediated PLC pathway. These data are consistent with previous results in which IGF-1R activated G i -mediated PLC activation and Ca 2ϩ mobilization (27,28). Inhibitors of these signal mediators suppressed Rg5-mediated FAK activation and angiogenesis, suggesting that G i protein-mediated elevation of [Ca 2ϩ ] i is responsible for FAK phosphorylation (35).…”
Section: Discussionsupporting
confidence: 93%
“…5A). Activation of the G i protein complex stimulates PLC activation and Ca 2ϩ mobilization, resulting in promotion of cell growth and migration (27,28). We next examined whether Rg5 regulates the G i protein-mediated PLC/Ca 2ϩ pathway.…”
Section: Rg5-induced Angiogenesis Requires G I Protein Plc and Camentioning
Background:The mechanism by which ginsenoside Rg5 regulates vascular function remains unclear. Results: Rg5 increases angiogenesis and vasorelxation by activating multiple signal transduction pathways downstream of insulin-like growth fastor-1 receptor (IGF-1R). Conclusion: Rg5 promotes endothelial cell function through activation of IGF-1R. Significance: These findings reveal a mechanism for the positive regulation of vascular function by Rg5-mediated IGF-1R activation.
“…Furthermore, in high-density primary cultures of human articular chondrocytes, application of verapamil or nifedipine abrogated the stimulatory effect of prostaglandin E2 (PGE2) on IGFBP-3, a protein that regulates the bioactivity and bioavailability of insulin-like growth factor-1 (IGF-1), an important mediator of chondrocyte metabolism [25]. In a followup study, IGF-1, IGF-2 and insulin all increased cytosolic Ca 2+ levels in cultured rabbit articular chondrocytes but through different mechanisms; Ca 2+ influx mediated by L-type VDCCs was involved downstream of IGF-1 and insulin, since verapamil diminished these responses [26].…”
Section: Vdccs and The Effects Of Nifedipine/verapamil On Chondrocytesmentioning
Chondrocytes, the single cell type in adult articular cartilage, have conventionally been considered to be non-excitable cells. However, recent evidence suggests that their resting membrane potential (RMP) is less negative than that of excitable cells, and they are fully equipped with channels that control ion, water, and osmolyte movement across the chondrocyte membrane. Among calcium-specific ion channels, members of the voltage-dependent calcium channel (VDCC) family are expressed in chondrocytes where they are functionally active. Ltype VDCC inhibitors such as nifedipine and verapamil have contributed to our understanding of the roles of these ion channels in chondrogenesis, chondrocyte signalling, and mechanotransduction. In this narrative review, we discuss published data indicating that VDCC function is vital for chondrocyte health, especially in regulating proliferation and maturation.We also highlight the fact that activation of VDCC function appears to accompany various inflammatory aspects of osteoarthritis (OA) and, based on in vitro data, the application of nifedipine and/or verapamil may be a promising approach for ameliorating OA severity.However, very few studies on clinical outcomes are available regarding the influence of calcium antagonists, which are used primarily for treating cardiovascular conditions in OA patients. This review is intended to stimulate further research on the chondrocyte 'channelome', contribute to the development of novel therapeutic strategies, and facilitate the retargeting and repositioning of existing pharmacological agents currently used for other comorbidities for the treatment of OA.
“…An increase in intracellular calcium can be achieved by an influx of Ca 2+ through voltage-dependent Ca 2+ channels located in the plasma membrane or by mobilization of Ca 2+ from intracellular stores (Cruzalegui & Bading 2000). IGF-I also increases intracellular Ca 2+ (Kojima et al 1988, Poiraudeau et al 1997). An increase in the intracellular calcium concentration decreased EPO secretion.…”
Growth hormone (GH) and insulin-like growth factor-I (IGF-I) play important roles in erythropoiesis and erythropoietin (EPO) secretion. We examined the effects of GH and IGF-I on EPO production in adult rat kidney and liver in vivo and in vitro. Male Wistar rats aged 8-10 weeks were used. Recombinant human GH (hGH) was continuously infused (20 µg/kg per h) subcutaneously for 48 h using a micro-osmotic infusion pump. Octreotide (10 µg/kg) was subcutaneously injected every 12 h beginning 12 h before the hGH treatment. GH increased plasma EPO levels earlier than it increased plasma IGF-I levels. At 24 h, the IGF-I content in the liver and kidney was increased from 172·8 14·6 to 232·6 17·8 ng/g tissue (means S.E.) and from 53·8 3·1 to 112·8 7·2 ng/g tissue, respectively. The EPO content in the liver was increased from 7·5 1·2 to 15·1 1·4 mIU/g tissue at 48 h, whereas the EPO content in the kidney was decreased at 12, 24, and 48 h after the start of hGH treatment. When the kidneys were organ-cultured, hGH considerably decreased EPO levels in the culture medium in a dose-related manner. The addition of anti-hGH IgG blunted the GH-induced inhibition of EPO secretion from the kidneys. IGF-I also decreased EPO levels in the medium in a dose-related manner. The addition of anti-IGF-I IgG blunted the IGF-I-induced inhibition of EPO secretion from the kidneys, whereas the GH-induced inhibition of EPO secretion was not affected. These findings suggest that both hGH and IGF-I have direct inhibitory effects on EPO secretion from adult rat kidneys.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.